H.R.3805 - Prescription Drug Rebate Reform Act of 2019116th Congress (2019-2020)
|Sponsor:||Rep. Gallagher, Mike [R-WI-8] (Introduced 07/17/2019)|
|Committees:||House - Energy and Commerce|
|Latest Action:||House - 07/18/2019 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.3805 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in House (07/17/2019)
Prescription Drug Rebate Reform Act of 2019
This bill requires private health insurance plans to set any coinsurance rate for a covered prescription drug based on the net price of the drug (the price after accounting for rebates and discounts provided by the drug manufacturer) and not the list price (the initial wholesale price set by the drug manufacturer). This requirement applies when a plan holder has an unmet deductible or other coinsurance obligation for prescription drug benefits under the plan.
The bill does not prohibit a plan from requiring a copayment provided that such copayment is not based on the cost of the drug.